Home
MedAlliance

MedAlliance Market Share Analysis for June 2026

Soluciones estratégicas impulsadas por IA, humanos y diseño sistémico.

Industry: N/A

Domainmedalliance.com

Year Founded2008

Employees51 - 200

Annual Revenue$10M - $15M

MedAlliance

MedAlliance (including company regionals)

medalliance.com

See more website traffic and engagement information

MedAlliance Revenue up to June 2026 is 10M - 15M

revenue generated by MedAlliance top domains

MedAlliance top domains revenue over 3 years

Revenue for MedAlliance top domains

medalliance.com10M - 15M

See more with Sales Intelligence

Total visits to MedAlliance's top domains

Understand MedAlliance market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in MedAlliance's top domains

Analyze MedAlliance engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on MedAlliance's top domains

See how MedAlliance keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

MedAlliance top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by MedAlliance

These are the website technologies, by industry, used by MedAlliance top domains

Widget (5)

Twemoji

Advertising (2)

DoubleClick

Email Services (2)

Microsoft Exchange Online

Mobile (2)

Meta Viewport

More Technologies

5

See all

News & Signals from MedAlliance

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsMedAlliance is developing Selution SLR.Geneva, Switzerland-based MedAlliance is developing a sustained drug-eluting balloon (DEB) that has been dubbed Selution SLR (Sustained Limus Release).

NewsCordis, LLC acquired MedAlliance for $35M on Oct 18th '22.2 October 2023 - Swiss-based medical technology company MedAlliance has been acquired by Cordis for a 2022 investment of $35M and a 2023 upfront closing payment of $200M, together with regulatory achievement milestones of up to $125M and commercial milestones of up to $775M through 2029, for a total consideration of up to $1.135 Billion.

NewsMedAlliance launches 1,660 patients in landmark SELUTION DeNovo study.MedAlliance announces enrollment of over 1,660 patients in landmark SELUTION DeNovo study.